News & Updates
Filter by Specialty:

Real-world study supports tralokinumab for difficult-to-treat AD
18 Oct 2024
byAudrey Abella
Interim data from the real-world TRACE study confirm the benefits of the high-affinity monoclonal antibody tralokinumab for individuals with moderate-to-severe head and neck atopic dermatitis (H&N AD) after up to 9 months of treatment.
Real-world study supports tralokinumab for difficult-to-treat AD
18 Oct 2024
Group intervention may prevent maternal obesity transmission
17 Oct 2024
A group prenatal care intervention appears beneficial in addressing several factors associated with intergenerational transmission of obesity, suggests a study in American Samoa.
Group intervention may prevent maternal obesity transmission
17 Oct 2024
Antipsychotic resistance tied to poorer cognitive function in schizophrenia
17 Oct 2024
byStephen Padilla
Resistance to antipsychotic treatment may result in worse cognitive function among patients with schizophrenia, with disorganization, doses, and negative symptoms playing a major role in this association, according to a Singapore study.